# Q500B second verification review: s75, Headache (after revision 3)

Reviewer: fresh independent QA agent. I did not write, edit or review this batch before. Both lenses (clinical truth, internal consistency and cueing). File reviewed in full: `src/samps/s75/headache.ts`, ids headache-48 to headache-52, against `docs/reviews/q500b-qa-s75.md`, `docs/reviews/q500b-verify-s75.md` and the writer report `docs/reviews/q500b-writer-s75.md` (revisions 1 to 3). No edits made to the batch (REVIEW-RULES rule 1).

## Checks run

- `SAMP_BATCH=s75 npx vitest run tests/samps.test.ts tests/samp-quality.test.ts tests/citations.test.ts --testTimeout=120000`: 128 of 128 pass, including the bank-wide near-duplicate stem test.
- House style: no em or en dashes in the file. The only semicolons are 5 in code lines (imports, constants, closing brackets), none in content. Canadian spelling (tumour, manoeuvres, pseudotumour, Paediatric). No personal names. No mnemonics. Thousands written "1 000 mg".
- Single key positions: first 4, second 4, third 4, fourth 4, fifth 3 of 19. Key feature coverage n1 3, n2 3, n3 4, n4 6, n5 3, n6 1. Five SAMPs.
- Whole bank keyword search (src/samps and src/cases, every batch): leptomeningeal, carcinomatous, numb chin, mental nerve, occipital neuralgia, occipital nerve, nerve block, cervicogenic, stabbing headache, Gradenigo, petrous, apicitis, cardiac cephalalgia, exertional headache, breastfe, LactMed, dihydroergotamine, pump and discard, sixth nerve, abducens, metoclopramide 10 mg IV, sumatriptan 50. Findings: leptomeningeal, cervicogenic, Gradenigo, petrous and cardiac cephalalgia appear nowhere else. Occipital neuralgia appears only as a distractor in s40 headache-25. "Nerve block" hits are all non-headache blocks (femoral, digital, fascia iliaca and similar). Breastfeeding items elsewhere are other drugs (antihypertensives, prednisone, methadone, SSRIs, contrast) or infant topics, none a migraine drug. Sixth nerve hits (s11, s40, s46, s37, batch15) are other causes (raised ICP, CVT, cavernous fistula, meningitis in a child on infliximab). No repeat that fails. See the note on metoclopramide under headache-50 q2.

## Sources verified (opened this review)

- EANO-ESMO 2023 leptomeningeal metastasis, full text through Europe PMC (PMC10619142; the PMC page itself showed a reCAPTCHA): "Multifocal clinical impairment is highly suggestive of LM", radicular signs including weakness, voiding and cauda equina problems, radicular neck and back pain, "LM should be considered, particularly in patients with breast or lung cancer or melanoma", MRI before lumbar puncture because LP may induce dural enhancement, brain and spinal MRI "on the same day or within an interval of not more than 7 days", CSF "ideally >10 ml but at least 5 ml", processed within 30 minutes, one repeat LP after negative or equivocal cytology. Supports every headache-48 claim.
- Schmit 2025 Gradenigo review, full text through Europe PMC (PMC12428227): meningeal enhancement in 15 patients (27%), sinus thrombosis in 8 (15%) on MRI, one fatality (2%), surgery 72%, triad and cephalosporin figures as earlier reviews reported. Supports headache-51 q2 to q4.
- CPS acute otitis media (https://cps.ca/en/documents/position/acute-otitis-media, reaffirmed 21 November 2024): acute mastoiditis the most common complication, pain or swelling over the mastoid bone behind the ear suggests it, AOM usually involves the mastoid air cells, sixth nerve palsy from petrous bone infection (Gradenigo), facial palsy, venous sinus thrombosis. Supports headache-51 q1 and q4.
- ICHD-3 13.4 occipital neuralgia (cited URL redirects to https://ichd-3.org/13-painful-cranial-neuropathies-and-other-facial-pains/13-4-occipital-neuralgia/): paroxysms of seconds to minutes, diminished sensation or dysaesthesia, allodynia on scalp or hair, tenderness or trigger points at the emergence of the greater occipital nerve, relief by local anaesthetic block (criterion D), fronto-orbital spread through trigeminocervical connections, must be distinguished from referral from atlantoaxial or upper zygapophyseal joints. Supports headache-49 q1, q2 and q4.
- ICHD-3 10.6 cardiac cephalalgia: "usually but not always aggravated by exercise", relieved by nitroglycerine, worsens and improves in parallel with ischemia, nausea, no photophobia or phonophobia, serious consequences if missed, triptans and ergots contraindicated in ischemic heart disease, both it and migraine can be triggered by exertion. Supports headache-52 q1 to q3.
- LactMed metoclopramide (PubMed record 30000411, updated 2026): most infants receive under 10% of the maternal weight-adjusted dose, and metoclopramide "should probably be avoided in women with a history of major depression". Supports the headache-50 q2 explanation's LactMed sentences.

Not opened by me, and not guessed: ESC 2023 ACS full text (not open access in PMC, and I did not spend WebFetch on it). The claim that dynamic ST-segment or T-wave changes are a high-risk criterion for an early invasive strategy within 24 hours matches my knowledge of the guideline and both earlier reviews. Blumenfeld 2013 AHS, Orr 2015 CHS, Do 2019 SNNOOP10 and the LactMed dihydroergotamine, sumatriptan, ketorolac and codeine records were verified by the first verification review, and the text has not changed since except as that review prescribed. I did not reopen them.

## Earlier fails: resolution

| Earlier fail | Resolved? |
|---|---|
| First review: 48 q1, 48 q2, 48 q3, 49 (zoster retelling), 50 q1, 50 q2, 50 q5, 51 q2, 51 q4, 52 q4 | Yes, all confirmed in the file. The verification review already confirmed these and nothing has regressed |
| Verification: 49 q1 lead-in mismatch | Yes. Prompt reads "Which of the following findings would most suggest a secondary cause that needs investigation?" |
| Verification: 49 q2 update cue and ICHD-3 overclaim | Yes. Update opens "The rest of his neurological examination is normal." Explanation says "meet the ICHD-3 clinical criteria ... which are completed when a local anesthetic block of the nerve eases the pain." |
| Verification: 49 q3 option names the q2 key | Yes. Key reads "Anesthetic nerve block", `correct` 0, not the longest option |
| Verification: 49 q4 update gives away the q3 key | Yes. Update reads "His attacks stop within 10 minutes of treatment. He asks whether a problem in his neck could be the cause." |
| Verification: 50 q4 LactMed misattribution | Yes. First two sentences are the prescribed wording |

Revision 3 made no unrequested changes (diffed against the verification review's prescriptions by reading).

## Verdicts

### headache-48 Leptomeningeal metastasis

| Q | Verdict | Finding |
|---|---|---|
| q1 | PASS | Key and distractor reasons true and supported by EANO-ESMO. |
| q2 | PASS | Right VI, left V3 (chin and lip), left lower motor neurone VII. Multifocal reasoning and site reasons true. |
| q3 | PASS | Key correct. Reasons against infarction, GBS, Lyme and GCA true. |
| q4 | PASS | MRI brain and spine with contrast plus CSF cytology after MRI matches EANO-ESMO. B6 cue from options to q3 stays flagged. |

### headache-49 Occipital neuralgia

| Q | Verdict | Finding |
|---|---|---|
| q1 | PASS | Long tract sign keyed. The four distractors are ICHD-3 features of the disorder or its comment on fronto-orbital spread. |
| q2 | PASS | Diagnosis correct. Explanation now accurate on criterion D. |
| q3 | PASS | Greater occipital nerve block supported by ICHD-3 and AHS consensus. Oxygen, triptan, metoclopramide and opioid reasons true. |
| q4 | PASS | Reduced painful neck rotation matches ICHD-3 11.2.1 C3 and the 13.4 comment. B6 hint from the options to q2 stays flagged. |

### headache-50 Migraine while breastfeeding

| Q | Verdict | Finding |
|---|---|---|
| q1 | PASS | Thunderclap onset as the SNNOOP10 flag. Onset fact is in the stem. Timeline consistent (onset 20:00, nasal DHE at 02:00, seen at 07:00). |
| q2 | PASS | Metoclopramide keyed. LactMed exposure and depression caution verified this review. Ketorolac, dexamethasone, DHE and opioid reasons true. |
| q3 | PASS | 3 days with pumped milk discarded, as LactMed reports the nasal spray manufacturer's advice. |
| q4 | PASS | Sumatriptan keyed. Revised LactMed wording accurate. Codeine, ketorolac, DHE and tramadol reasons true. |

### headache-51 Petrous apicitis in a child

| Q | Verdict | Finding |
|---|---|---|
| q1 | PASS | Matches CPS. Left abduction failure is a left VI palsy, consistent with the left ear. |
| q2 | PASS | Gradenigo triad correct. Distractor reasons true. |
| q3 | PASS | IV ceftriaxone before the flight is the single best option. LP and oral or topical reasons true. |
| q4 | PASS | Key and numbers (27%, 15%, one death) verified against Schmit. |

### headache-52 Cardiac cephalalgia

| Q | Verdict | Finding |
|---|---|---|
| q1 | PASS | Relief within minutes of rest keyed. ICHD-3 notes exertion can trigger migraine too, so the key rightly rests on the rapid resolution, not exertion alone. |
| q2 | PASS | ECG first. B6 cue from the q3 update stays flagged. |
| q3 | PASS | Nitroglycerin, BP 154/90, no PDE5 inhibitor. Triptan contraindication as ICHD-3 states it. |
| q4 | PASS | Early invasive assessment, consistent with ESC 2023 (full text not opened). |

## Notes for the physician (judgement points, not fails)

1. headache-50 q2: IV metoclopramide 10 mg for ED migraine is already keyed in signed s40 SAMPs (medication overuse and coronary disease variants) and in the s11 pregnancy menu. Here the deciding facts are lactation specific (ketorolac labelling, ergot class during nursing), so I judge it a new decision and not a D1 repeat. The physician may still see the "special population, metoclopramide wins" pattern as one too many.
2. headache-50 q2 and q4: ketorolac is rejected on the manufacturer's breastfeeding contraindication, while CHS strongly recommends it and some lactation references treat brief NSAID use as acceptable beyond the newborn period. Confirm the physician accepts labelling as the deciding reason.
3. headache-50 q3: the 3 day pump-and-discard key rests on the US nasal spray labelling as reported by LactMed. Confirm it matches Canadian product information.
4. headache-50 sources: the LactMed citation text lists entries on dihydroergotamine, ketorolac, codeine and sumatriptan, but q2 also draws on the metoclopramide entry. Optional tidy-up: add "metoclopramide" to the list of entries.
5. headache-49 q3: evidence for occipital nerve block is mostly consensus (AHS), and ED availability varies.
6. headache-49 source URL: the ICHD-3 13.4 link works through a 301 redirect. Optional: point it at the canonical address above.
7. headache-48 q3: Lyme is rejected on "no tick exposure in the city", but the stem only says no tick bites. Many Lyme patients recall no bite. The key is still clearly best given the cancer history.
8. headache-51 q4: in mock mode the distractor "Tenderness behind the ear" points loosely at the area of the q1 key. It does not name the q1 answer, so I leave it.
9. headache-52 q4: no Canadian NSTE-ACS guideline is cited. ESC 2023 is the current standard in use.
10. Standing B6 flags carried forward: headache-48 q4 options (cue q3), headache-49 q4 options (hint q2), headache-52 q3 update (cues q2).

## Key changes

None made (reviewers do not edit).

## Summary

5 SAMPs, 20 questions (19 single, 1 menu). Every fail from the first review and from the verification review is resolved, and revision 3 changed nothing else. Every number I could check against the open sources (EANO-ESMO, Schmit, CPS, ICHD-3, LactMed metoclopramide) is correct. No repeat found anywhere in the bank. House style clean. Tests pass. Only ESC 2023 full text was not opened.

Overall: PASS
